Showing results (41-50 of 4,010) with videos related to
Sort By:
Pageof 401
Archives of Biochemistry and Biophysics|May 1, 1985
Activation of normal and abnormal human factor IX with trypsinD M Monroe, C M Noyes, D L Straight, et al.The Journal of Biological Chemistry|December 5, 1990
Comparative platelet binding and kinetic studies with normal and variant factor IXa moleculesS S Ahmad, R Rawala-Sheikh, D M Monroe, et al.Thrombosis Research|December 1, 1989
Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factorD S Telgt, B G Macik, D M McCord, et al.Biochemistry|August 26, 1986
p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombinA D Turner, D M Monroe, H R Roberts, et al.The Journal of Clinical Investigation|August 15, 1997
Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia BJ Y Chang, D M Monroe, D W Stafford, et al.Journal of Thrombosis and Haemostasis : JTH|February 8, 2011
Platelet binding and activity of a factor VIIa variant with enhanced tissue factor independent activityM Hoffman, Z Volovyk, E Persson, et al.Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Thrombin generation in vascular tissueA Pathak, R Zhao, D M Monroe, et al.Journal of Thrombosis and Haemostasis : JTH|April 12, 2007
Tissue factor around dermal vessels has bound factor VII in the absence of injuryM Hoffman, C M Colina, A G McDonald, et al.Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.Blood|May 1, 1989
Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe, D M McCord, M N Huang, et al.Pageof 401